Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Treasury Shares: 2018-2025

Historic Treasury Shares for Bicycle Therapeutics (BCYC) over the last 4 years, with Sep 2025 value amounting to $1.7 million.

  • Bicycle Therapeutics' Treasury Shares rose 118.30% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 118.30%. This contributed to the annual value of $674,262 for FY2024, which is 106.29% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Treasury Shares stood at $1.7 million, which was down 6.22% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Treasury Shares registered a high of $1.9 million during Q1 2025, and its lowest value of $187,725 during Q1 2022.
  • In the last 3 years, Bicycle Therapeutics' Treasury Shares had a median value of $780,926 in 2024 and averaged $916,160.
  • Data for Bicycle Therapeutics' Treasury Shares shows a peak YoY spiked of 141.08% (in 2023) over the last 5 years.
  • Bicycle Therapeutics' Treasury Shares (Quarterly) stood at $187,725 in 2022, then soared by 74.11% to $326,848 in 2023, then soared by 106.29% to $674,262 in 2024, then soared by 118.30% to $1.7 million in 2025.
  • Its Treasury Shares stands at $1.7 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.9 million for Q1 2025.